Trial Profile
A Prospective, Randomized, Double-blinded, Active-control, 3-Treatment Arm, Parallel, Multi-center, Phase 2 Trial to Evaluate Safety and Efficacy With CDFR0812-15/25mg and CDFR0812-15/50mg Compared to Clomipramine HCl 15mg in Male Patients Diagnosed With Premature Ejaculation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2017
Price :
$35
*
At a glance
- Drugs Clomipramine/sildenafil (Primary) ; Clomipramine
- Indications Premature ejaculation
- Focus Therapeutic Use
- Sponsors CTCBIO
- 16 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 16 Oct 2015 New trial record